ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.37 USD 1.48% Market Closed
Market Cap: 229.9m USD
Have any thoughts about
ATAI Life Sciences NV?
Write Note

ATAI Life Sciences NV
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ATAI Life Sciences NV
Total Current Liabilities Peer Comparison

Comparables:
BAYN
MRK
93M1
DMP
PSG

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
ATAI Life Sciences NV
NASDAQ:ATAI
Total Current Liabilities
$20.1m
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Total Current Liabilities
€31.6B
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
8%
Merck KGaA
XETRA:MRK
Total Current Liabilities
€9.9B
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
7%
MPH Health Care AG
XETRA:93M1
Total Current Liabilities
€5m
CAGR 3-Years
2%
CAGR 5-Years
73%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Total Current Liabilities
€439.6m
CAGR 3-Years
40%
CAGR 5-Years
21%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Total Current Liabilities
€24.6m
CAGR 3-Years
24%
CAGR 5-Years
27%
CAGR 10-Years
N/A

See Also

What is ATAI Life Sciences NV's Total Current Liabilities?
Total Current Liabilities
20.1m USD

Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Total Current Liabilities amounts to 20.1m USD.

What is ATAI Life Sciences NV's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 3Y
18%

Over the last year, the Total Current Liabilities growth was 1%. The average annual Total Current Liabilities growth rates for ATAI Life Sciences NV have been 18% over the past three years .

Back to Top